YRMC also has $38.9 million of series 2013B, 2002, and 1997B bonds outstanding, which are not rated by Fitch but are incorporated into the analysis.
The rating affirmation was supported by a number of factors, including the hospital’s recovering profitability, dominant market position, solid liquidity and sound debt metrics.
The rating outlook is stable. Despite the revenue and expense pressures anticipated in the rest of 2015, Fitch expects YRMC to continue producing profitable and debt coverage metrics consistent with the rating.
More articles on healthcare finance:
For-profit hospital stock report: Week of June 15-19
If Supreme Court strikes subsidies, health system profits would likely take a small hit
4 things the CFO needs to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
